NOTE PURCHASE AGREEMENT

    THIS NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of June 15, 2021, (the “Execution Date”), is entered into by and
      between QRONS INC., a Wyoming corporation (the “Company”), and QUICK CAPITAL, LLC, a Wyoming limited liability company (the “Buyer”). Each capitalized term
      used herein shall have the meaning ascribed thereto in Section 10 below, or as otherwise defined herein.

    WHEREAS, the Company and the Buyer are executing and delivering this Agreement in reliance upon an exemption from securities registration
      afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”); and

    WHEREAS, the Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this
      Agreement (i) a convertible promissory note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $115,000.00 (together with any note(s) issued in replacement thereof or as a dividend thereon or
      otherwise with respect thereto in accordance with the terms thereof, the “Note”), convertible into shares (the “Conversion Shares”) of common stock, $0.0001 par value per share, of the Company (the “Common Stock”) pursuant to the
      terms of the Note; and (ii) warrants to acquire up to 115,000 shares (the “Warrant Shares”) of Common Stock in the form attached hereto as Exhibit B (the “Warrant”).

    NOW THEREFORE, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
      receipt and adequacy of which are hereby acknowledged, the Company and the Buyer hereby agree as follows:

    
      	
              1.

            	
              PURCHASE AND SALE OF SECURITIES.

            


    

    
      	
              (a)

            	
              Issuance of Securities. On the Closing Date (as defined below), the Company shall sell and issue to the Buyer and the Buyer shall purchase and fund the Note (the “Investment”).
                On the Closing Date, the Company shall issue to the Buyer, as a commitment fee, the Warrant to purchase the Warrant Shares.

            


    

    
      	
              (b)

            	
              Closing Date. Subject to the satisfaction (or written waiver) of the conditions set forth in Section 7 and Section 8 below, the date of the sale and issuance of the
                Note and the Warrant constituting the Investment pursuant to this Agreement (the “Closing Date”) shall be the Execution Date. The closing of the transactions contemplated by this Agreement (the “Closing”) shall occur on the
                Closing Date at such location as may be agreed to by the parties.

            


    

    
      	
              (c)

            	
              Form of Payment. On the Closing Date, by wire transfer of immediately available funds, in accordance with the Company’s written wiring instructions against delivery of the Note,
                the Buyer shall pay the purchase price of $100,000.00 (the “Purchase Price”) for the Investment of $115,000.00 (which amount includes an original issuance discount of 10% and with $3,500.00 being withheld to offset transaction and
                legal costs of the Buyer), as evidenced by the Note.

            


    

    
      1

      
        


    

    
      	
              2.

            	
              REPRESENTATIONS AND WARRANTIES OF THE BUYER. The Buyer represents and warrants to the Company that as of the Execution Date:

            


    

    
      	
              (a)

            	
              Investment Purpose. As of the Execution Date, the Buyer is purchasing the Securities for its own account for investment only and not with a view towards the public sale or
                distribution thereof, except pursuant to sales registered or exempted from registration under the Securities Act; provided, however, that by making the foregoing representation and warranty, the Buyer does not agree to hold
                any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under the Securities Act.

            


    

    
      	
              (b)

            	
              Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of United
                States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth
                herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the Securities.

            


    

    
      	
              (c)

            	
              Information. The Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Company and materials relating to
                the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Notwithstanding the foregoing, the Company
                has not disclosed to the Buyer any material non-public information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries
                nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below.

            


    

    
      	
              (d)

            	
              Authorization; Enforcement; Organization. This Agreement has been duly and validly authorized by the Buyer. This Agreement has been duly executed and delivered on behalf of the
                Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms. The Buyer is a limited liability company organized under the laws of the State of Wyoming.

            


    

    
      	
              (e)

            	
              Accredited Investor Status. The Buyer is (i) an “accredited investor” as that term is defined in Rule 501 of the General Rules and Regulations under the Securities Act by reason of
                Rule 501(a)(3) (an “Accredited Investor”), (ii) experienced in making investments of the kind described in this Agreement and the related documents, (iii) able, by reason of the business and financial experience of its officers (if
                an entity) and professional advisors (who are not affiliated with or compensated in any way by the Company or any of its Affiliates or selling agents), to protect its own interests in connection with the transactions described in this
                Agreement, and the related documents, and (iv) able to afford the entire loss of its investment in the Securities.

            


    

    
      	
              (f)

            	
              General Solicitation. The Buyer is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any
                newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement.

            


       

      

      
        2

        
          


      

    

    
      	
              3.

            	
              REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company represents and warrants to the Buyer that as of the Execution Date and the Closing Date (or as of such other time
                expressly specified below):

            


    

    
      	
              (a)

            	
              Corporate Governance Compliance:

            


    

    
      	
              (i)

            	
              Issuance of Securities. The Note has been duly authorized and is being validly issued to the Buyer. The Conversion Shares have been duly authorized and fully reserved for issuance
                and, upon conversion of the Note in accordance with its terms, will be validly issued, fully paid and non-assessable, and free from all taxes, Liens, claims and encumbrances with respect to the issue thereof, with the holders being entitled
                to all rights accorded to a holder of Common Stock. The Conversion Shares shall not be subject to pre-emptive rights or other similar rights of stockholders of the Company (except to the extent already waived) and will not impose personal
                liability upon the holder thereof, other than restrictions on transfer provided for in the Transaction Documents and under the Securities Act.  The Warrant has been duly authorized and is being validly issued to the Buyer. The Warrant
                Shares have been duly authorized and fully reserved for issuance and, upon exercise of the Warrant in accordance with its terms, will be validly issued, fully paid and non-assessable, and free from all taxes, Liens, claims and encumbrances
                with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. The Warrant Shares shall not be subject to pre-emptive rights or other similar rights of stockholders of the Company
                (except to the extent already waived) and will not impose personal liability upon the holder thereof, other than restrictions on transfer provided for in the Transaction Documents and under the Securities Act.

            


    

    
      	
              (ii)

            	
              Organization and Qualification. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Wyoming, with the requisite
                corporate power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company  is not in violation or default of any of the provisions of its certificate or articles of
                incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
                conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect and
                no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

            


    

    
      	
              (iii)

            	
              Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and the other Transaction
                Documents. The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate
                action, and no further consent or authorization of the Company or its board of directors or stockholders is required. Each of this Agreement and the other Transaction Documents has been duly executed and delivered by the Company and
                constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, or similar laws relating to, or
                affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

            


      
        3

        
          


      

    

    
      	
              (iv)

            	
              Capitalization. As of the Execution Date, the authorized capital stock of the Company is as set forth in the SEC Documents (as defined below). Except as set forth on Schedule
                  3(a)(iv), the Company has not issued any capital stock since its most recently filed SEC Document, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common
                Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed SEC Document. Except as disclosed in
                the SEC Documents, no shares are reserved for issuance pursuant to the Company’s stock option plans, no shares are reserved for issuance pursuant to the terms of any Common Stock Equivalents (other than the Note and the Warrant) exercisable
                for, or convertible into or exchangeable for shares of Common Stock and sufficient shares are reserved for issuance upon conversion of the Note and upon exercise of the Warrant (as required by the Note, the Warrant and Transfer Agent
                Instruction Letter). All of such outstanding shares of capital stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. No shares of capital stock of the Company are subject to preemptive rights
                or any other similar rights of the stockholders of the Company or any liens or encumbrances imposed through the actions or failure to act of the Company. Except as disclosed in the SEC Documents, as of the Execution Date, (i) there are no
                outstanding options, warrants, scrip, rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights of any character whatsoever relating to, or securities or rights
                convertible into or exchangeable for any shares of capital stock of the Company, or arrangements by which the Company  is or may become bound to issue additional shares of capital stock of the Company, (ii) there are no agreements or
                arrangements under which the Company is obligated to register the sale of any of its  securities under the Securities Act and (iii) there are no anti-dilution or price adjustment provisions contained in any security issued by the Company
                (or in any agreement providing rights to security holders) that will be triggered by the issuance of the Securities. The Company has filed in its SEC Documents true and correct copies of the Company’s articles of incorporation as in effect
                on the Execution Date, the Company’s bylaws, as in effect on the Execution Date, and the terms of all securities convertible into or exercisable for Common Stock of the Company and the material rights of the holders thereof in respect
                thereto. The Company shall provide the Buyer a certification of this representation signed by the Company’s Chief Executive Officer on behalf of the Company as of the Closing Date.

            


    

    
      	
              (v)

            	
              No Conflicts. The execution, delivery and performance of this Agreement and the other Transaction Documents by the Company and the consummation by the Company of the transactions
                contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the Conversion Shares and the Warrant Shares) will not (a) result in a violation of the Company’s  articles of incorporation,
                by-laws or other organizational or charter documents, (b) conflict with, or constitute a material default (or an event that with notice or lapse of time or both would become a material default) under, result in the creation of any Lien upon
                any of the properties or assets of the Company, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture, instrument or any “lock-up” or similar provision of any underwriting or
                similar agreement to which the Company  is a party, or (c) result in a violation of any federal, state or local law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations) applicable to the
                Company  or by which any property or asset of the Company  is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the aggregate, have
                a Material Adverse Effect), nor is the Company otherwise in violation of, conflict with or in default under any of the foregoing. The business of the Company is not being conducted in violation of any law, ordinance or regulation of any
                governmental entity, except for possible violations that either singly or in the aggregate do not and will not have a Material Adverse Effect. The Company is not required under federal, state or local law, rule or regulation to obtain any
                consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to issue the Conversion Shares or the Warrant Shares or to execute, deliver or perform any of its obligations
                under this Agreement or the other Transaction Documents (other than any SEC, FINRA or state securities filings that may be required to be made by the Company subsequent to Closing).

            


      
        4

        
          


      

    

    
      	
              (b)

            	
              SEC and Offering Compliance:

            


    

    
      	
              (i)

            	
              SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities
                Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one (1) year preceding the Execution Date (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
                materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Documents”) on a timely basis or has received a valid extension of such time of filing and
                has filed any such SEC Documents prior to the expiration of any such extension. As of their respective dates, the SEC Documents complied in all material respects with the requirements of the Securities Act and the Exchange Act, as
                applicable, and other federal laws, rules and regulations applicable to such SEC Documents, and none of the SEC Documents when filed contained any untrue statement of a material fact or omitted to state a material fact required to be stated
                therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Documents (the “Financial Statements”)
                comply as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the SEC or other applicable rules and regulations with respect thereto. Such Financial Statements
                have been prepared in accordance with generally accepted accounting principles applied on a consistent basis during the periods involved (except (a) as may be otherwise indicated in such Financial Statements or the notes thereto or (b) in
                the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements) and fairly present in all material respects the financial position of the Company as of the dates thereof and
                the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments). The Company maintains a system of internal accounting controls
                appropriate for its size. There is no transaction, arrangement, or other relationship between the Company and an unconsolidated or other off balance sheet entity that is not disclosed by the Company in its Financial Statements or otherwise
                that would be reasonably likely to have a Material Adverse Effect. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other
                Person acting on its behalf has provided the Buyer or its agents or counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Buyer will
                rely on the foregoing representation in effecting transactions in securities of the Company.

            


       

      

      
        5

        
          


      

    

    
      	
              (ii)

            	
              Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of an arm’s length purchaser with
                respect to the Transaction Documents and the transactions contemplated hereby and thereby and that the Buyer is neither (i) an officer or director of the Company, nor (ii) an “affiliate” (as defined in Rule 144) of the Company.   The
                Company further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and
                any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Buyer’s purchase of the Securities.  The
                Company further represents to the Buyer that the Company’s decision to enter into the Transaction Documents has been based solely on the independent evaluation by the Company and its representatives.

            


    

    
      	
              (iii)

            	
              No Integrated Offering. Neither the Company, nor any person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any
                offers to buy any security under circumstances that would require registration under the Securities Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not be integrated with any other
                issuance of the Company’s securities (past, current or future) for purposes of any stockholder approval provisions applicable to the Company or its securities.

            


    

    
      	
              (iv)

            	
              No Brokers. No broker is entitled to a commission payable by the Company in connection with the transactions contemplated by this transaction and the Company has taken no action
                which would give rise to any claim by any person for brokerage commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.

            


    

    
      	
              (v)

            	
              Disclosure. All information relating to or concerning the Company  set forth in this Agreement and provided to the Buyer pursuant in connection with the transactions contemplated
                hereby is true and correct in all material respects and the Company has not omitted to state any material fact necessary in order to make the statements made herein or therein, in light of the circumstances under which they were made, not
                misleading. No event or circumstance has occurred or exists with respect to the Company  or its  business, properties, prospects, operations or financial conditions, which, under applicable law, rule or regulation, requires public
                disclosure or announcement by the Company but which has not been so publicly announced or disclosed.

            


       

      

      
        6

        
          


      

    

    
      	
              (vi)

            	
              Shell Company Status. The Company is not currently an issuer identified in Rule 144(i)(1)(i) under the Securities Act, and, if it was at any time previously been such an issuer,
                then the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, has filed all reports and other materials required to be filed by Section 13 or 15(d) of the Exchange Act, as applicable during the
                preceding 12 months, and, as of a date at least one year prior to the Execution Date, has filed current “Form 10 information” with the SEC (as defined in Rule 144(i)(3) of the Securities Act) reflecting its status as an entity that is no
                longer an issuer described in Rule 144(i)(1)(i) of the Securities Act.

            


    

    
      	
              (vii)

            	
              No Disqualification Events.  With respect to Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act (“Regulation D Securities”), none
                of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting
                equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”
                and, together, “Issuer Covered Persons”) is subject to any of the “bad actor” disqualifying events described in Rule 506(d)(1)(i)(viii) under the Securities Act (each, a “Disqualification Event”), except for a Disqualification
                Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.  The Company has complied, to the extent applicable, with its
                disclosure obligations under Rule 506(e).

            


    

    
      	
              (viii)

            	
              Other Covered Persons. The Company is not aware of any Person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for
                solicitation of buyers or potential purchasers in connection with the sale of any Regulation D Securities.

            


    

    
      	
              (ix)

            	
              No General Solicitation; Placement Agent.  Neither the Company, nor any of its  Affiliates, nor any Person acting on its , has engaged in any form of general solicitation or
                general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities.  The Company has not engaged any placement agent in connection with the sale of the Securities.  In the event that a
                broker-dealer or other agent or advisory is engaged by the Company subsequent to the initial Closing, the Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, or brokers’ commissions (other
                than for persons engaged by any Buyer or its investment advisor) relating to or arising out of the transactions contemplated hereby in connection with the sale of the Securities. The Company shall pay, and hold the Buyer harmless against,
                any liability, loss or expense (including, without limitation, reasonable attorney’s fees and out-of-pocket expenses reasonably incurred) arising in connection with any such claim.

            


       

      

      
        7

        
          


      

    

    
      	
              (x)

            	
              Investment Company Status.  The Company is not, and upon consummation of the sale of the Securities will not be, an “investment company,” a company controlled by an “investment
                company” or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment company” as such terms are defined in the Investment Company Act of 1940, as amended.

            


    

    
      	
              (xi)

            	
              Transfer Taxes.  On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in connection with the sale and transfer
                of the Securities to be sold to the Buyer hereunder will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have been complied with.

            


    

    
      	
              (c)

            	
              Operations Related:

            


    

    
      	
              (i)

            	
              Absence of Certain Changes. No event has occurred that would have a Material Adverse Effect on the Company  that has not been disclosed in the SEC Documents. Without limiting the
                generality of the foregoing, except as disclosed in the SEC Documents,  the Company has not taken any of the actions set forth on Schedule 3(c)(i).

            


    

    
      	
              (ii)

            	
              Absence of Litigation. Except as disclosed in the SEC Documents, there are no actions, suits, investigations, inquiries or proceedings pending or, to the Knowledge of the Company,
                threatened against or affecting the Company,  or any of its properties, nor has the Company received any written or oral notice of any such action, suit, proceeding, inquiry or investigation, which would have a Material Adverse Effect or
                would require disclosure under the Securities Act or the Exchange Act. No judgment, order, writ, injunction or decree or award has been issued by or, to the Knowledge of the Company, requested of any court, arbitrator or governmental agency
                which would have a Material Adverse Effect. Except as disclosed in the SEC Documents or as set forth on Schedule 3(c)(ii) there has not been, and to the Knowledge of the Company, there is not pending or contemplated, any
                investigation by the SEC involving the Company, or any current or former director or officer of the Company.

            


    

    
      	
              (iii)

            	
              Patents, Copyrights, etc. The Company  owns or possesses adequate rights or licenses to use all material trademarks, trade names, service marks, service mark
                registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals, governmental authorizations, trade secrets and rights necessary to conduct its business as now conducted (“Intellectual Property”).
                None of the Company’s Intellectual Property rights have expired or terminated, and no Intellectual Property material to the Company will expire or terminate within the 12 months following the Execution Date.   The Company does not have any
                Knowledge of any infringement by the Company of any material trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks, service mark registrations, trade secret or other similar
                rights of others, or of any such development of similar or identical trade secrets or technical information by others, and there is no claim, action or proceeding being made or brought against, or to the Company’s Knowledge, being
                threatened against, the Company regarding trademark, trade name, patents, patent rights, invention, copyright, license, service names, service marks, service mark registrations, trade secret or other infringement, which could reasonably be
                expected to have a Material Adverse Effect.

            


      
        8

        
          


      

    

    
      	
              (iv)

            	
              Tax Status. The Company has made or filed all federal and material state and foreign income and all other material tax returns, reports and declarations required by any
                jurisdiction to which it is subject (unless and only to the extent that the Company has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes) and has paid all taxes and other governmental
                assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably adequate for the
                payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the
                officers of the Company know of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating to the assessment or collection of any foreign, federal, state or local tax. None of the
                Company’s tax returns is presently being audited by any taxing authority.

            


    

    
      	
              (v)

            	
              Certain Transactions. Except as set forth in the SEC Documents, none of the officers or directors of the Company , and to the Knowledge of the Company, none of the employees of the
                Company is presently a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by,
                providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the Knowledge of the Company, any entity in which any officer, director, or any such
                employee has a substantial interest or is an officer, director, trustee or partner, in each case in excess of the lesser of (i) $120,000 or (ii) one percent of the average of the Company’s total assets at year end for the last two completed
                fiscal years, other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any
                stock option plan of the Company.

            


    

    
      	
              (vi)

            	
              Permits; Compliance. The Company  is in possession of all franchises, grants, authorizations, licenses, permits, easements, variances, exemptions, consents, certificates,
                approvals and orders necessary to own, lease and operate its properties and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there is no action pending or, to the Knowledge of the
                Company, threatened regarding suspension or cancellation of any of the Company Permits. The Company is not in conflict with, or in default or violation of, any of the Company Permits, except for any such conflicts, defaults or violations
                which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.  The Company has not received any notification with respect to possible conflicts, defaults or violations of applicable laws,
                except for notices relating to possible conflicts, defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.

            


    

    
      	
              (vii)

            	
              Environmental Matters. The Company is in compliance with all applicable Environmental Laws in all respects except where the failure to comply does not have and could not
                reasonably be expected to have a Material Adverse Effect. For purposes of the foregoing: “Environmental Laws” means, collectively, the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, the
                Superfund Amendments and Reauthorization Act of 1986, the Resource Conservation and Recovery Act, the Toxic Substances Control Act, as amended, the Clean Air Act, as amended, the Clean Water Act, as amended, any other “Superfund” or
                “Superlien” law or any other applicable federal, state or local statute, law, ordinance, code, rule, regulation, order or decree regulating, relating to, or imposing liability or standards of conduct concerning, the environment or any
                Hazardous Material.

            


      
        9

        
          


      

    

    
      	
              (viii)

            	
              Title to Property. Except as disclosed in the SEC Documents, the Company and each Subsidiary has good and marketable title in fee simple to all real property owned by it and good
                and marketable title in all personal property owned by it that is material to the business of the Company, in each case free and clear of all Liens and, except for Liens as do not materially affect the value of such property and do not
                materially interfere with the use made and proposed to be made of such property by the Company and Liens for the payment of federal, state or other taxes, the payment of which is neither delinquent nor subject to penalties.  Any real
                property and facilities held under lease by the Company is held under valid, subsisting and enforceable leases with which the Company is in compliance with such exceptions as are not material and do not interfere with the use made and
                proposed to be made of such property and buildings by the Company.

            


    

    
      	
              (ix)

            	
              Internal Accounting Controls. Except as disclosed in the SEC Documents, the Company maintains a system of internal accounting controls sufficient, in the judgment of the Company’s
                board of directors, to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
                statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded
                accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is in compliance with all provisions of the Sarbanes-Oxley Act of 2002, as
                amended, which are applicable to it.

            


    

    
      	
              (x)

            	
              Foreign Corrupt Practices. The Company,  nor any director, officer, agent, employee or other person acting on behalf of the Company has, in the course of his actions for, or on
                behalf of, the Company, used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made any direct or indirect unlawful payment to any foreign or domestic
                government official or employee from corporate funds; violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence payment, kickback or other
                unlawful payment to any foreign or domestic government official or employee.

            


    

    
      	
              (xi)

            	
              Solvency. The Company (after giving effect to the transactions contemplated by this Agreement) is solvent (i.e., its assets have a fair market value in excess of the amount
                required to pay its probable liabilities on its existing debts as they become absolute and matured) and currently the Company has no information that would lead it to reasonably conclude that the Company would not, after giving effect to
                the transaction contemplated by this Agreement, have the ability to, nor does it intend to take any action that would impair its ability to, pay its debts from time to time incurred in connection therewith as such debts mature. Except as
                disclosed in the SEC Documents or on Schedule 3(c)(xi), the Company did not receive a qualified opinion from its auditors with respect to its most recent fiscal year end and, after giving effect to the transactions contemplated by
                this Agreement, does not anticipate or know of any basis upon which its auditors might issue a qualified opinion in respect of its current fiscal year. For the avoidance of doubt any qualification of the auditors’ opinion relating to the
                Company’s ability to continue as a “going concern” shall not, by itself, be a violation of this Section 3(c)(xi).

            


      
        10

        
          


      

    

    
      	
              (xii)

            	
              Insurance. The Company has no lack of insurance coverage that could potentially materially and adversely affect the condition, financial or otherwise, or the earnings, business or
                operations of the Company.

            


    

    
      	
              (xiii)

            	
              No Undisclosed Events, Liabilities, Developments or Circumstances.  Except as set forth in the SEC Documents, the Company has no liabilities or obligations of any nature (whether
                accrued, absolute, contingent, unasserted or otherwise and whether due or to become due) other than those liabilities or obligations that are disclosed in the Financial Statements or which do not exceed, individually in excess of $50,000
                and in the aggregate in excess of $200,000.  The reserves, if any, established by the Company or the lack of reserves, if applicable, are reasonable based upon facts and circumstances known by the Company on the Execution Date and there are
                no loss contingencies that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards Board which are not provided for in the Financial Statements.

            


    

    
      	
              (xiv)

            	
              Management.  During the past five year period, no current or former officer or director or, to the Knowledge of the Company, stockholder of the Company  has been the subject of
                any matter that would require disclosure under Paragraph (f) of Rule 401 of Regulation S-K that has not been publicly disclosed.

            


    

    
      	
              (xv)

            	
              Assets; Title. Except as disclosed on Schedule 3(c)(xv), the Company  has good and valid title to, or a valid leasehold interest in, as applicable, all of its properties
                and assets, free and clear of all Liens except (i) any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate reserves have been established in accordance with GAAP, (ii) any
                statutory Lien arising in the ordinary course of business by operation of law with respect to a liability that is not yet due or delinquent, (iii) any Lien created by operation of law, such as materialmen’s liens, mechanics’ liens and other
                similar liens, arising in the ordinary course of business with respect to a liability that is not yet due or delinquent or that are being contested in good faith by appropriate proceedings, and (iv) such as have been disposed of in the
                ordinary course of business.  To the Company’s Knowledge, all tangible personal property owned by the Company has been maintained in good operating condition and repair, except (x) for ordinary wear and tear, and (y) where such failure
                would not have a Material Adverse Effect.  To the Company’s Knowledge, all assets leased by the Company  are in the condition required by the terms of the lease applicable thereto during the term of such lease and upon the expiration
                thereof.  To the Company’s Knowledge, the Company has good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company,  free
                and clear of all Liens, encumbrances and defects.  Any real property and facilities held under lease by the Company are held by it  under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere
                with the use made and proposed to be made of such property and buildings by the Company.

            


      
        11

        
          


      

    

    
      	
              (xvi)

            	
              Books and Records.  To the Company’s Knowledge, the books of account, ledgers, order books, records and documents of the Company accurately and completely reflect all information
                relating to the business of the Company, the nature, acquisition, maintenance, location and collection of each of its  assets, and the nature of all transactions giving rise to material obligations or accounts receivable of the Company,
                except where the failure to so reflect such information would not have a Material Adverse Effect.  To the Company’s Knowledge, the minute books of the Company contain accurate records in all material respects of all meetings and accurately
                reflect all other actions taken by the stockholders, boards of directors and all committees of the boards of directors, and other governing Persons of the Company.

            


    

    
      	
              (xvii)

            	
              Money Laundering.  The Company is  in compliance with, and have not previously violated, the USA PATRIOT ACT of 2001 and all other applicable U.S. and non-U.S. anti-money
                laundering laws and regulations, including, but not limited to, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive Order
                13224 of September 23, 2001 entitled, “Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079 (2001)); and (ii) any regulations contained in 31 CFR, Subtitle B,
                Chapter V.

            


    

    
      	
              (d)

            	
              General

            


    

    
      	
              (i)

            	
              Acknowledgment of Dilution. The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance of the Conversion Shares upon conversion
                of the Note. The Company further acknowledges that its obligation to issue Conversion Shares upon conversion of the Note is absolute and unconditional regardless of the dilutive effect that such issuances may have on the ownership interests
                of other stockholders of the Company. The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance of the Warrant Shares upon exercise of the Warrant. The Company further acknowledges that
                its obligation to issue Warrant Shares upon exercise of the Warrant is absolute and unconditional regardless of the dilutive effect that such issuances may have on the ownership interests of other stockholders of the Company.

            


    

    
      	
              (ii)

            	
              Breach of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties set forth in this Section 3, and in addition to
                any other remedies available to the Buyer pursuant to this Agreement, it will be considered an Event of Default under the Note.

            


    

    
      	
              (iii)

            	
              Absence of Schedules. In the event that at the Closing Date, the Company does not deliver and attach hereto any disclosure schedule contemplated by this Agreement, the Company
                hereby acknowledges and agrees that (i) each such undelivered disclosure schedule shall be deemed to read as follows: “Nothing to Disclose”, and (ii) the Buyer has not otherwise waived delivery of such disclosure schedule.

            


      
        12

        
          


      

    

    
      	
              4.

            	
              GENERAL COVENANTS.

            


    

    
      	
              (a)

            	
              Best Efforts. The parties hereto shall use their commercially reasonable best efforts to satisfy timely each of the conditions described in Section 7 and 8 of this
                Agreement.

            


    

    
      	
              (b)

            	
              Financial Information. The Company agrees to send or make available the following reports to the Buyer until the Buyer transfers, assigns, or sells all of the Securities: (i)
                within ten (10) days after the filing with the SEC, a copy of its Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K; (ii) within one (1) day after release, copies of all press releases issued
                by the Company  relating to the transactions contemplated hereby; and (iii) contemporaneously with the making available or giving to the stockholders of the Company, copies of any notices or other information the Company makes available or
                gives to such stockholders. For the avoidance of doubt, filing the documents required in (i) above via EDGAR or releasing any documents set forth in (ii) above via a recognized wire service shall satisfy the delivery requirements of this Section

                  4(c).

            


    

    
      	
              (c)

            	
              Listing. The Company shall work in good faith to secure the listing of the Conversion Shares and the Warrant Shares upon each national securities exchange or automated quotation
                system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and, so long as the Buyer owns any of the Securities, shall maintain, so long as any other shares of Common Stock shall be so listed,
                such listing of all Conversion Shares, and all Warrant Shares from time to time issuable upon exercise of the Note and the Warrant, respectively. The Company will obtain and, so long as the Buyer owns any of the Securities, maintain the
                listing and trading of its Common Stock on the Trading Market and will comply in all material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”)

                and such exchanges, as applicable.

            


    

    
      	
              (d)

            	
              Corporate Existence. So long as the Buyer beneficially owns any of the Securities, the Company shall maintain its corporate existence and shall not sell all or substantially all of
                the Company’s assets, except in the event of a merger or consolidation or sale of all or substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i) assumes the Company’s obligations hereunder
                and under the agreements and instruments entered into in connection herewith and (ii) is a publicly traded corporation whose Common Stock is listed or quoted for trading on the Trading Market.

            


    

    
      	
              (e)

            	
              No Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances that would require registration of the Securities
                being offered or sold hereunder under the Securities Act or cause the offering of the Securities to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval provision applicable to the
                Company or its securities.

            


    

    
      	
              (f)

            	
              Failure to Comply with the Exchange Act. So long as the Buyer beneficially owns any of the Securities, the Company shall comply with the reporting requirements of the Exchange Act;
                and the Company shall continue to be subject to the reporting requirements of the Exchange Act.

            


    

    
      	
              (g)

            	
              Breach of Covenants. If the Company breaches any of the covenants set forth in this Section 4, then in addition to any other remedies available to the Buyer pursuant to
                this Agreement, each such breach will be considered an “Event of Default” under the Note.

            


      
        13

        
          


      

    

    
      	
              (h)

            	
              Indemnification. Each party hereto (an “Indemnifying Party”) agrees to indemnify and hold harmless the other party along with its officers, directors, employees, and
                authorized agents, and each Person or entity, if any, who controls such party within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act or the rules and regulations thereunder (an “Indemnified Party”)
                from and against any Damages, joint or several, and any action in respect thereof to which the Indemnified Party becomes subject to, resulting from, arising out of or relating to any misrepresentation, breach of warranty or nonfulfillment
                of or failure to perform any covenant or agreement on the part of the Indemnifying Party contained in this Agreement.

            


    

    
      	
              5.

            	
              SPECIAL COVENANTS

            


    

    
      	
              (a)

            	
              Use of Proceeds. The Company shall use the proceeds from the sale of the Note to for working capital, preparation for additional financing, and other general corporate purposes and
                shall not, directly or indirectly, use such proceeds for any loan to or investment in any other corporation, partnership, enterprise or other person.

            


    

    
      	
              (b)

            	
              Certain Expenses and Fees. The Company shall pay all stamp taxes and other taxes and duties levied in connection with the delivery of the Note to the Buyer. In addition, the Buyer
                shall receive a $3,500.00 credit for the Buyer’s transaction expenses which shall be evidenced in the face value of the Note. The Company shall pay all fees and costs charged by its transfer agent in connection with processing any
                conversion/exercise of the Note and/or Warrant by the Buyer.

            


    

    
      	
              (c)

            	
              Reservation of Shares. The Company covenants that while the Note and/or Warrant remain outstanding, the Company will reserve from its authorized and unissued Common Stock, one
                hundred percent (100%) of the number of shares of Common Stock, free from pre-emptive rights, that would be issuable upon full, unconditioned conversion of the Note and exercise of the Warrant calculated on the basis of the conversion price
                and exercise price, respectively, in effect as the Closing Date, which such reserved amounts shall be increased by the Company from time to time in accordance with its obligations under such Securities. In addition to all other rights in
                this Agreement and the Note, in the event that on any date (the “Reserve Depletion Date”) the Company does not have available enough authorized shares of Common Stock to satisfy any conversion request regarding the Note, or exercise
                of the Warrant, the Company shall repay all outstanding amounts owed under the Note in full within sixty (60) days of the Reserve Depletion Date, at the election of the Buyer.

            


    

    
      	
              (d)

            	
              Piggyback Registration Rights. The Company shall include on any registration statement (except on a registration statement on Form S-8) filed with the SEC, all Conversion Shares,
                and all Warrant Shares. In addition to all other remedies at law or in equity or otherwise under this Agreement or other Transaction Documents, failure to do so will result in liquidated damages of $15,000.00 pursuant to this Section
                  5(d), being immediately due and payable to the Buyer at its election in the form of cash payment.

            


    

    
      	
              (e)

            	
              Variable Rate Transactions. [Deleted]

            


    

    
      	
              (f)

            	
              Regulation A Offering. [Deleted]

            


    

    
      	
              (g)

            	
              Participation Rights. During the twelve (12) months immediately following the Closing, with respect to each and any securities offering conducted by the Company, the Company agrees
                to, and hereby does, irrevocably grant to the Buyer the option to purchase up to $115,000 worth of the securities offered in such offering at the applicable prices thereunder.

            


      
        14

        
          


      

    

    
      	
              (h)

            	
              Repayment from Proceeds. [Deleted]

            


    

    
      	
              (i)

            	
              Right of First Refusal. During the twelve (12) months immediately following the Closing, in the event that the Company receives a Bona Fide Offer (defined below) of capital or
                financing from any third party consisting of any securities offering, including but not limited to any debt or equity securities, then the Company must, and irrevocably agrees to, first offer such opportunity to the Buyer to provide such
                capital or financing to the Company on the same or similar terms as each respective third party’s terms, and the Buyer may in its sole discretion determine whether the Buyer will provide such capital or financing. Upon receipt of the third
                party offer, the Company shall promptly provide notice thereof to the Buyer (the “Offer Notice”) and provide copies of the pending transaction documents. Should the Buyer be unwilling or unable to provide such capital or financing to
                the Company within two (2) Trading Days from the Buyer’s receipt of the Offer Notice from the Company, then the Company may obtain such capital or financing from the respective third party upon the exact same terms and conditions offered by
                the Company to the Buyer, which transaction must be completed within seven (7) Trading Days after the date of the Offer Notice.  If the Company does not receive the capital or financing from the respective third party within seven (7)
                Trading Days after the date of the respective Offer Notice, then the Company must again offer the capital or financing opportunity to the Buyer as described above, and the process detailed above shall be repeated.  A “Bona Fide Offer”
                is one in which the purchaser is irrevocably and contractually bound to purchase the subject securities from the Company, subject to the Buyer’s right of first refusal.

            


    

    
      	
              (j)

            	
              Uplisting to National Exchange. [Deleted]

            


    

    
      	
              (k)

            	
              Compliance with Rule 15c2-11. While any of the Securities are outstanding, the Company will take all actions to maintain as publicly available all information required by paragraph
                (b) of Rule 15c2-11 of the Exchange Act (as effective on September 26, 2021), as amended, such that brokers or dealers attempting to publish any quotation for the Common Stock or, directly or indirectly, to submit any such quotation for
                publication, shall be able to comply with Rule 15c2-11(a).

            


    

    
      	
              (l)

            	
              Prohibition on Certain Transactions. The Buyer covenants and agrees that while it holds the Note, neither it, nor any affiliate acting on its behalf or pursuant to any
                understanding with it will execute any “short sales” of the Common Stock as defined in Rule 200 of Regulation SHO under the Exchange Act.

            


    

    
      	
              (m)

            	
              Breach of Covenants. If the Company breaches any of the covenants set forth in this Section 5, then in addition to any other remedies available to the Buyer pursuant to
                this Agreement, each such breach will be considered an “Event of Default” under the Note.

            


       

      

      
        15

        
          


      

    

    
      	
              6.

            	
              TRANSFER AGENT INSTRUCTIONS. Prior to registration of the Conversion Shares and the Warrant Shares under the Securities Act or the date on which the Conversion Shares or the
                Warrant Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then be immediately sold, all such certificates shall bear the restrictive legend specified in the Note
                or Warrants as applicable. The Company warrants that unless required by law validated by court order: (i) no stop transfer instructions will be given by the Company to its Transfer Agent and that the Securities shall otherwise be freely
                transferable on the books and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its Transfer Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring
                (or issuing) (electronically or in certificated form) any certificate for Conversion Shares or Warrant Shares to be issued to the Buyer upon conversion/exercise of or otherwise pursuant to the Note or the Warrant, respectively, as and when
                required by the Note, the Warrant or this Agreement; and (iii) it will not fail to remove (or direct its Transfer Agent not to remove) or impair, delay, and/or hinder its Transfer Agent from removing) any restrictive legend (or to withdraw
                any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares or any Warrant Shares as contemplated by the terms of this Agreement, the Note and the Warrant, as applicable. Nothing in this Section shall
                affect in any way the Buyer’s obligations and agreement to comply with all applicable prospectus delivery requirements, if any, upon re-sale of the Securities. If the Buyer provides the Company (which shall be at the cost of the Company,
                not to exceed $750.00), with (i) an opinion of counsel in form, substance and scope customary for opinions in comparable transactions and reasonably satisfactory to the Company’s transfer agent, to the effect that a public sale or transfer
                of such Securities may be made without registration under the Securities Act and such sale or transfer is effected or (ii) the Buyer provides reasonable assurances that the Securities can be sold pursuant to Rule 144, the Company shall
                permit the transfer, and, in the case of the Conversion Shares and the Warrant Shares, promptly instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as specified
                by the Buyer.  The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company
                acknowledges that the remedy at law for a breach of its obligations under this Section may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be
                entitled, in addition to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being required.

            


    

    
      	
              7.

            	
              CONDITIONS PRECEDENT TO THE COMPANY’S OBLIGATIONS TO SELL. The obligation of the Company hereunder to issue and sell the Note and the Warrant to the Buyer at the Closing is subject
                to the satisfaction, at or before the Closing Date, of each of the following conditions thereto, provided that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

            


    

    
      	
              (a)

            	
              The Buyer shall have executed this Agreement and delivered the same to the Company.

            


    

    
      	
              (b)

            	
              The Buyer shall have delivered the Purchase Price in accordance with Section 1 above.

            


    

    
      	
              (c)

            	
              The representations and warranties of the Buyer shall be true and correct in all material respects as of the Closing Date (except for representations and warranties that speak as of a
                specific date), and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer at or
                prior to the Closing Date.

            


      
        16

        
          


      

    

    
      	
              (d)

            	
              No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
                authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

            


    

    
      	
              8.

            	
              CONDITIONS PRECEDENT TO THE BUYER’S OBLIGATION TO PURCHASE. The obligation of the Buyer hereunder to purchase the Note and fund the Investment of the Note at the Closing is subject
                to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:

            


    

    
      	
              (a)

            	
              The Company shall have executed this Agreement and delivered the same to the Buyer on the Closing Date.

            


    

    
      	
              (b)

            	
              The Company shall have delivered to the Buyer the duly executed Note in accordance with Section 1 above on the Closing Date.

            


    

    
      	
              (c)

            	
              The Company shall have delivered to the Buyer the duly executed Warrant on the Closing Date.

            


    

    
      	
              (d)

            	
              The Company shall have delivered to the Buyer the duly executed Transfer Agent Instruction Letter on the Closing Date.

            


    

    
      	
              (e)

            	
              The Company shall have delivered a copy of its Directors’ resolutions relating to the transactions contemplated hereby, the form of which is attached hereto as Exhibit D, on the
                Closing Date.

            


    

    
      	
              (f)

            	
              No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
                authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement, as of the Closing
                Date.

            


    

    
      	
              (g)

            	
              No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited to a change in the Exchange Act reporting status
                of the Company or the failure of the Company to be timely in its Exchange Act reporting obligations, as of the Closing Date.

            


    

    
      	
              (h)

            	
              The Company shall have delivered to the Buyer a copy of its certificate of good standing with the State of Wyoming dated within five (5) days of the Closing.

            


    

    
      	
              (i)

            	
              The representations and warranties of the Company shall be true and correct in all material respects as of the Closing Date as though made at such time (except for representations and
                warranties that speak as of a specific date, which shall be true and correct in all material respects as of such specific date) and the Company shall have performed, satisfied and complied in all material respects with the covenants,
                agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Buyer shall have received a certificate or certificates, executed by the chief executive
                officer of the Company, dated as of the Closing Date, to the foregoing effect.

            


       

      

      
        17

        
          


      

    

    
      	
              9.

            	
              GOVERNING LAW; MISCELLANEOUS.

            


    

    
      	
              (a)

            	
              Governing Law.  This Agreement shall be governed by and construed in accordance with the laws of the State of Wyoming without regard to principles of conflicts of laws. Any action
                brought by either party against the other concerning the transactions contemplated by this Agreement shall be brought only in the state courts of Miami, Florida, or in the federal courts located in the Southern District of Florida. The
                parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The
                prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or
                unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such
                provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process and consents to
                process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such
                party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
                right to serve process in any other manner permitted by law.

            


    

    
      	
              (b)

            	
              JURY TRIAL WAIVER.  THE COMPANY AND THE BUYER HEREBY WAIVE A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER OF THE PARTIES HERETO
                AGAINST THE OTHER IN RESPECT OF ANY MATTER ARISING OUT OF OR IN CONNECTION WITH THE TRANSACTION DOCUMENTS.

            


    

    
      	
              (c)

            	
              Counterparts; Signatures by Electronic Mail. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
                one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. This Agreement, once executed by a party, may be delivered to the other party hereto by electronic mail
                transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

            


    

    
      	
              (d)

            	
              Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this Agreement.

            


    

    
      	
              (e)

            	
              Severability. In the event that any provision of this Agreement or of any of the Transaction Documents is invalid or unenforceable under any applicable statute or rule of law, then
                such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law
                shall not affect the validity or enforceability of any other provision hereof.

            


    

    
      	
              (f)

            	
              Entire Agreement; Amendments. This Agreement and the Transaction Documents referenced herein contain the entire understanding of the parties with respect to the matters covered
                herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be
                waived or amended other than by an instrument in writing signed by the Buyer.

            


      
        18

        
          


      

    

    
      	
              (g)

            	
              Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein,
                shall be (a) personally served, (b) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (c) delivered by reputable air courier service with charges prepaid, or (d) transmitted by hand delivery, or
                e-mail as a PDF (with read receipt), addressed as set forth below or to such other address as such party shall have specified most recently by written notice given in accordance herewith. Any notice or other communication required or
                permitted to be given hereunder shall be deemed effective (i) upon hand delivery or delivery by e-mail (with read receipt) at the address designated below (if delivered on a business day during normal business hours where such notice is to
                be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (ii) on the second business day following the date of mailing by
                express courier service or on the fifth business day after deposited in the mail, in each case, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.

            


    

    If to the Company, to:

    QRONS INC.

    50 Battery Place, #7T,

    New York, New York 10280

    Attn: Jonah Meer, Chief Executive Officer and Chief Financial Officer

    E-mail: jmeer@qrons.com

    

    

    If to the Buyer, to:

    QUICK CAPITAL, LLC

    12000 Biscayne Blvd

    Suite 408

    Miami, FL 33181

    Attn: Eilon D. Natan, Manager

    E-mail: eilon@quick-cap.com

    

    

    Either party hereto may from time to time change its address or e-mail for notices under this Section 9(g) by giving at least ten (10) days’ prior written notice of such
      changed address to the other party hereto.

    
      	
              (h)

            	
              Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither the Company nor the Buyer shall
                assign this Agreement or any rights or obligations hereunder without the prior written consent of the other. Notwithstanding the foregoing, subject to Section 2(e), the Buyer may assign its rights hereunder to any person that
                purchases Securities in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the Exchange Act, without the consent of the Company.

            


    

    
      	
              (i)

            	
              Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns and is not for the benefit of, nor
                may any provision hereof be enforced by, any other person.

            


    

    
      	
              (j)

            	
              Survival. The representations and warranties of the Company and the Buyer and the agreements and covenants set forth in this Agreement shall survive the Closings hereunder as well
                as the termination/satisfaction of the Note for the longest period allowable under applicable law. The Company agrees to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for Damages arising as a
                result of or related to any breach by the Company of any of its representations, warranties and covenants set forth in this Agreement or any of its covenants and obligations under this Agreement. including advancement of expenses as they
                are incurred.

            


      
        19

        
          


      

    

    
      	
              (k)

            	
              Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements,
                certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

            


    

    
      	
              (l)

            	
              No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict
                construction will be applied against any party.

            


    

    
      	
              (m)

            	
              Remedies.

            


    

    
      	
              (i)

            	
              The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating the intent and purpose of the transaction contemplated
                hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this
                Agreement, that the Buyer shall be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
                of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any bond or other security being required.

            


    

    
      	
              (ii)

            	
              In addition to any other remedy provided herein or in any document executed in connection herewith, the Company shall pay the Buyer for all costs, fees and expenses in connection with any
                arbitration, litigation, contest, dispute, suit or any other action to enforce any rights of the Buyer against the Company in connection herewith, including, but not limited to, costs and expenses and reasonable attorneys’ fees, and costs
                and time charges of counsel to the Buyer.

            


    

    
      	
              (n)

            	
              Publicity. The Company and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC, Trading Market, or FINRA filings, or any
                other public statements with respect to the transactions contemplated hereby; provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, Trading Market
                or FINRA filings with respect to such transactions as is required by applicable law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall be provided
                with a copy thereof).

            


    

    
      	
              10.

            	
              DEFINED TERMS. As used in this Agreement, the following terms shall have the following meanings specified or indicated (such meanings to be equally applicable to both the singular
                and plural forms of the terms defined):

            


      
        20

        
          


      

    

    “Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under
      common control with, such Person, and the term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of
      such Person, whether through ownership of voting securities, by contract or otherwise.

    “Common Stock Equivalents” means any securities of the Company that would entitle the holder thereof to acquire at any time Common Stock, including, without limitation,
      any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

    “Damages” shall mean any loss, claim, damage, liability, cost and expense (including, without limitation, reasonable attorneys’ fees and disbursements and costs and
      expenses of expert witnesses and investigation).

    “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

    “Hazardous Material” means and includes any hazardous, toxic or dangerous waste, substance or material, the generation, handling, storage, disposal, treatment or emission
      of which is subject to any Environmental Law.

    “Knowledge” including the phrase “to the Company’s Knowledge” shall mean the actual knowledge after reasonable investigation by the Company’s officers and
      directors.

    “Lien” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, pre-emptive right or any other restriction.

    “Material Adverse Effect” means any effect on the business, operations, properties, or financial condition of the Company that is material and adverse to the Company 
      and/or any condition, circumstance, or situation that prohibits or otherwise materially interferes with the ability of the Company  to enter into and/or perform its obligations under any Transaction Document.

    “Person” means an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government or political subdivision or an
      agency or instrumentality thereof.

    “Securities” means, collectively, the Note, the Conversion Shares, the Warrant, the Warrant Shares, and any other securities of the Company issued in connection with or in
      exchange for any of the foregoing.

     “Trading Day” shall mean a day on which the NASDAQ stock market shall be open for business.

    “Trading Market” means the OTCQB market of the OTC-Markets.

    “Transaction Documents” shall mean this Agreement, the Note, the Warrant, the Transfer Agent Instruction Letter and all schedules and exhibits hereto and thereto.

    “Transfer Agent” shall mean VStock Transfer LLC, the current transfer agent of the Company, and any successor transfer agent of the Company.

    “Transfer Agent Instruction Letter” means the letter from the Company to the Transfer Agent in the form of Exhibit C attached hereto.

    ** signature page follows **

    
      21

      
        


    

    IN WITNESS WHEREOF, the Buyer and the Company have caused their respective signature page to this Note Purchase Agreement to be duly
      executed as of the Execution Date.

    

    

    	 	
            COMPANY:

             

            QRONS INC.

             

             

             

            By: /s/Jonah Meer

            

            Name: Jonah Meer

            Title: CEO, CFO

             

             

            BUYER:

             

          
	 	
            QUICK CAPITAL, LLC

             

            By: /s/Eilon D. Natan

            

            Name: Eilon D. Natan

            Title: Manager

             

             

             

          
	 	 


     

    
      22

      
        


    

    DISCLOSURE SCHEDULES

    

    

    

    

    

    

    
      23

      
        


    

    Schedule 3(c)(i)

    

    

    Except as disclosed in the SEC Documents, the Company has not:

    (1) declared, set aside or paid any dividend or other
        distribution with respect to any shares of capital stock of the Company or any direct or indirect redemption, purchase or other acquisition of any such shares;

    (2) sold, assigned, pledged, encumbered, transferred
        or otherwise disposed of any tangible asset of the Company (other than sales or the licensing of its products to customers in the ordinary course of business consistent with past practice), or sold, assigned, pledged, encumbered, transferred or
        otherwise disposed of any Intellectual Property (as defined below), other than licensing of products of the Company in the ordinary course of business and on a non-exclusive basis;

    (3) entered into any licensing or other agreement
        with regard to the acquisition or disposition of any Intellectual Property other than licenses in the ordinary course of business consistent with past practice or any amendment or consent with respect to any licensing agreement filed or required to
        be filed with respect to any governmental authority;

    (4) made capital expenditures, individually or in the
        aggregate, in excess of $100,000;

    (5) incurred any obligation or liability (whether
        absolute, accrued, contingent or otherwise, and whether due or to become due) on the Company’s behalf , in excess of $100,000 individually, other than obligations under customer contracts, current obligations and liabilities, in each case incurred
        in the ordinary course of business and consistent with past practice;

    (6) had any Lien on any property of the Company 
        except as disclosed in the SEC Documents;

    (7) made any payment, discharge, satisfaction or
        settlement of any suit, action, claim, arbitration, proceeding or obligation of the Company, except in the ordinary course of business and consistent with past practice;

    (8) effected any split, combination or
        reclassification of any equity securities;

    (9) sustained any material loss, destruction or
        damage to any property of the Company, whether or not insured;

    (10) effected any acceleration or prepayment of any
        indebtedness for borrowed money or the refunding of any such indebtedness;

    (11) experienced any labor trouble involving the
        Company  or any material change in their personnel or the terms and conditions of employment;

    (12) made any waiver of any valuable right, whether
        by contract or otherwise;

    (13) made any loan or extension of credit to any
        officer or employee of the Company;

    (14) made any change in the independent public
        accountants of the Company or any material change in the accounting methods or accounting practices followed by the Company or any material change in depreciation or amortization policies or rates;

    (15) experienced any resignation or termination of
        any officer, key employee or group of employees of the Company;

    (16) effected any change in any compensation
        arrangement or agreement with any employee, officer, director or stockholder that would result in the aggregate compensation to such Person in such year to exceed $100,000;

    (17) effected any material increase in the
        compensation of employees of the Company (including any increase pursuant to any written bonus, pension, profit sharing or other benefit or compensation plan, policy or arrangement or commitment), or any increase in any such compensation or bonus
        payable to any officer, stockholder, director, consultant or agent of the Company having an annual salary or remuneration in excess of $100,000;

    (18) made any revaluation of any of its respective
        assets, including, without limitation, writing down the value of capitalized inventory or writing off notes or accounts receivable or any sale of assets other than in the ordinary course of business;

    (19) made any acquisition or disposition of any
        material assets (or any contract or arrangement therefor), or any other material transaction by the Company otherwise than for fair value in the ordinary course of business;

    (20) written-down the value of any asset of the
        Company  or written-off as uncollectible of any accounts or notes receivable or any portion thereof except in the ordinary course of business and in a magnitude consistent with historical practice;

    (21) cancelled any debts or claims or any material
        amendment, termination or waiver of any rights of the Company; or

    (22) entered into any agreement, whether in writing
        or otherwise, to take any of the actions specified in the foregoing items (1) through (21).